Who is sponsoring NCT05833776?

NCT05833776 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05833776?

Interventions in NCT05833776: spinal anesthesia using hyperbaric bupivacaine 0.5% (3ml) with fentanyl (25ug).

What condition does NCT05833776 study?

NCT05833776 studies Post Operative Pain.

Is NCT05833776 still recruiting?

NCT05833776 is currently completed. Last updated 11 July 2023.

Last reviewed 2023-07-11 · How we verify

NCT05833776

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Value of IPACK Block (Interspace Between the Popliteal Artery and Capsule of Knee) With Spinal Anesthesia Versus Fentanyl Based Spinal Anesthesia for Knee Arthroscopic Meniscectomy

Completed NA Last updated 11 July 2023

What this trial tests

NA trial testing spinal anesthesia using hyperbaric bupivacaine 0.5% (3ml) with fentanyl (25ug) in Post Operative Pain in 60 participants. Completed in 1 June 2023.

Timeline

1 January 2022

Primary endpoint
1 February 2022

1 June 2023

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	60
Start date	1 January 2022
Primary completion	1 February 2022
Estimated completion	1 June 2023
Sites	1 location across Egypt

Drugs / interventions tested

spinal anesthesia using hyperbaric bupivacaine 0.5% (3ml) with fentanyl (25ug)

Conditions studied

Post Operative Pain — all drugs for Post Operative Pain →

Sponsor

Al-Azhar University

Who can join

Adults 25 to 60, any sex, with Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative analgesia is provided by local anesthesia combined with intrathecal narcotics. In addition, for the first 24 hours, this combination has a parenteral opioid sparing effect. However, despite its benefits, this method has been associated to an increased incidence of urine retention, nausea, and vomiting, as well as pruritus. A new localized analgesic approach called as IPACK (infiltration between the knee capsule and the popliteal artery) has been employed in practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05833776 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 11 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05833776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing